Kyverna Therapeutics, Inc. (KYTX) Live Share Price, Invest From India

Kyverna Therapeutics, Inc. Stock Performance

as on September 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$7.00
Day's Price Range
$7.19
$7.13
1.82%
Downside
0.84%
Upside
52 Week's Low
52 Week's High
$4.40
52-Week Price Range
$13.67
$7.13
38.29%
Downside
91.73%
Upside

Kyverna Therapeutics, Inc. share price movements today

Previous Close: $7.04
Open: $7.05
Volume: 592.7K
Market Cap: $426.7M
Day's Low - High: $7.00 - $7.19
52 Week Low - High: $4.40 - $13.67

Kyverna Therapeutics, Inc. Historical Returns

1 Month Return: -20.63 %
3 Month Return: -12.76 %
1 Year Return: + 21.38 %
3 Year Return: 0 %
5 Year Return: 0 %

Kyverna Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Kyverna Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$426.7M

EPS (TTM)

-2.7696

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-87.24%

Kyverna Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kyverna Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Kyverna Therapeutics, Inc.	BUY	$426.7M	NA	NA	0.00%	0.00%
Moderna	BUY	$63.1B	-63.24%	-19.81	-12.57%	0.00%
Vertex Pharmaceuticals	BUY	$130.1B	174.21%	29.81	86.04%	0.00%
Regeneron	BUY	$79.7B	21.1%	18.48	84.86%	0.48%

Stock Returns calculator for Kyverna Therapeutics, Inc. Stock including INR - Dollar returns

The Kyverna Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Kyverna Therapeutics, Inc. investment value today

Current value as on today

₹1,33,787

Returns

₹33,787

(+33.79%)

Returns from Kyverna Therapeutics, Inc. Stock

₹22,931 (+22.93%)

Dollar Impact

₹10,856 (+10.86%)

Analyst Recommendation on Kyverna Therapeutics, Inc. Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Kyverna Therapeutics, Inc.. Average target price of $30.4

Kyverna Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Kyverna Therapeutics, Inc..

What analysts predicted

76.55%UPSIDE

Target Price

$30.4

Current Price

$7.13

Analyzed by

4 Analysts

Target

$30.40

Kyverna Therapeutics, Inc. target price $30.4, a slight upside of 76.55% compared to current price of $7.13. According to 4 analysts rating.

Indian Investors' Interest in Kyverna Therapeutics, Inc. Stock

Search interest for Kyverna Therapeutics, Inc. Stock has increased by 108% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 21, 2026 to September 20, 2026

Change:108% versus previous 30 day period

Kyverna Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	2	-	-	-	-	-	-
Gross Profit	0	0	-29	0	0	0	0	0	0	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	0	-28	-34	-37	-44	-42	-36	-37	-39	-38
Net Profit Margin	0.00%	0.00%	0.00%	-1852.22%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Kyverna Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	5	7	-	-	-
Gross Profit	5	7	-1	-2	-1
Operating Income	-	-	-	-	-
EBITDA	-	-	-	-	-
Interest Expense	-	-	-	-	-
Depreciation	-	-	-	-	-
Income Before Tax	-	-	-	-	-
Income Tax Expense	-	-	-	-	-
Net Income	-26	-28	-60	-127	-161
Net Profit Margin	-465.88%	-411.29%	0.00%	0.00%	0.00%

Mutual Funds that own Kyverna Therapeutics, Inc. Stock

Check out the Mutual Funds with significant holdings in Kyverna Therapeutics, Inc..

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	2.81993%	1743942
T. ROWE PRICE HEALTH SCIENCES FUND, INC.	1.846858%	1142161
Fidelity Concord Street Trust	0.409157%	253037
Bridgeway Funds, Inc.	0.227995%	141000
WesMark Funds	0.178353%	110300

See all

Global Institutional Holdings in Kyverna Therapeutics, Inc.

Funds	Holdings
Vanguard	3.55%
iShares	3.27%
James E. Flynn	3.23%
Michael Rockefeller	1.37%
Fidelity	0.77%

See all

Insights on Kyverna Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 487.4%
NEGATIVE IMPACT
Price Dip
In the last 1 month, KYTX stock has moved down by -19.6%

About Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.

Organisation	Kyverna Therapeutics, Inc.
Headquarters	5980 Horton Street, Emeryville, CA, 94608, US
Industry	Biotechnology
CEO	Warner Biddle
E-voting on shares	Click here to vote

Key Management of Kyverna Therapeutics, Inc.

Name	Title
Dr. Naji H. Gehchan M.B.A., M.D.	Chief Medical & Development Officer
Mr. Gregory Martini	Chief Financial Officer
Dr. Tom Van Blarcom Ph.D.	Senior VP & Head of Research
Mr. Mayo Pujols	Chief Technology Officer
Ms. Jessica Serra	Head of Investor Relations
Ms. Cara Bauer Ph.D.	Chief Human Resources Officer
Ms. Christi L. Shaw	Executive Chairperson
Mr. Warner Biddle	CEO & Director
Mr. Ritesh Srivastava	Chief Legal & Compliance Officer
Ms. Tracy Rossin	Senior Vice President of Corporate Affairs

FAQs

What is Kyverna Therapeutics, Inc. share price today?

Kyverna Therapeutics, Inc. share price today is $7.13 as on September 19, 2026 at 8:45 am IST at the close of the market. Kyverna Therapeutics, Inc. share today touched a day high of $7.19 and a low of $7.00.

What is the 52 week high and 52 week low for Kyverna Therapeutics, Inc. share?

Kyverna Therapeutics, Inc. share touched a 52 week high of $13.67 on January 1, 1970 and a 52 week low of $4.40 on January 1, 1970. Kyverna Therapeutics, Inc. stock price today i.e. September 19, 2026 at 8:45 am IST is closed at $7.13,which is 47.84% down from its 52 week high and 62.05% up from its 52 week low.

What is Kyverna Therapeutics, Inc.'s market capitalisation today?

Kyverna Therapeutics, Inc. market capitalisation is $0.00T as on September 19, 2026 at 8:45 am IST.

How to invest in Kyverna Therapeutics, Inc. Stock (KYTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kyverna Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kyverna Therapeutics, Inc. Shares that will get you 0.2104 shares as per Kyverna Therapeutics, Inc. share price of $7.13 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Kyverna Therapeutics, Inc. Stock (KYTX) from India?

Indian investors can start investing in Kyverna Therapeutics, Inc. (KYTX) shares with as little as ₹95.88 or $1 (as of September 20, 2026 at 12:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Kyverna Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 20, 2026 at 12:40 am IST). Based on Kyverna Therapeutics, Inc. share’s latest price of $7.13 as on September 19, 2026 at 8:45 am IST, you will get 1.4025 shares of Kyverna Therapeutics, Inc.. Learn more about fractional shares .